Menu
/REGISTER
Montecito
Nixon Peabody
Pac Premier
Loading...
You are here:  Home  >  'AstraZeneca'
Latest

Study finds Amgen asthma drug is effective

By   /  Thursday, September 7th, 2017  /  Central Coast Health Watch, Latest news  /  Comments Off on Study finds Amgen asthma drug is effective

An asthma drug being developed by Thousand Oaks-based Amgen and AstraZeneca showed significant yearly reduction for patients, according to a study published in the New England Journal of Medicine Sept. 6. Patients with severe, uncontrolled asthma using tezepelumab saw a drop in annual exacerbation compared with patients taking a placebo, Amgen said in a news Read More →

Read More →
Latest

Amgen sells Colorado facility to AstraZeneca for $64.5 million

By   /  Tuesday, October 11th, 2016  /  Central Coast Health Watch, Latest news, Real Estate  /  Comments Off on Amgen sells Colorado facility to AstraZeneca for $64.5 million

Thousand Oaks biotech giant Amgen continued its Colorado exit plans recently as it sold a Longmont, Colo., facility to London-based pharmaceutical and biotech company AstraZeneca for $64.5 million. Amgen built the 692,000-square-foot facility in the 1990s to make ingredients for its blockbuster anti-anemia drug Epogen. The site used large vats to produce lines of cell Read More →

Read More →
Latest

Amgen, AstraZeneca strike drug development deal

By   /  Monday, April 2nd, 2012  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen, AstraZeneca strike drug development deal

Amgen has entered a development deal with London-based AstraZeneca to jointly commercialize five anti-inflammation drugs. Under the terms of the agreement announced April 2, AstraZeneca will pay a one-time $50 million payment to Amgen and will be responsible for helping the Thousand Oaks-based biotech giant commercialize its inflammation drug pipeline. The firms said in a Read More →

Read More →